Research Article

Autophagic Network Analysis of the Dual Effect of Sevoflurane on Neurons Associated with GABARAPL1 and 2

Table 2

Identification of direct protein targets of sevoflurane using DTome.

Searched_Drug (1/1)Target (8)Action
NumberDB_IDNameTarget_SymbolUniProt ID

1DB01236SevofluraneGABRA1P14867Agonist
2DB01236SevofluraneGLRA1P23415Agonist
3DB01236SevofluraneGRIA1P42261Antagonist
4DB01236SevofluraneKCNA1Q09470Inducer
5DB01236SevofluraneATP2C1P98194Inhibitor
6DB01236SevofluraneATP5DP30049Other/unknown
7DB01236SevofluraneMT-ND1P03886Unknown
8DB01236SevofluraneGABRA1/2/3/4/5/6P14867/P47869/P34903/P48169/P31644/Q16445PAM
8DB01236SevofluraneGABRB1/2/3, GABRD, GABREP18505/P47870/28472, Q14764, P78334PAM
8DB01236SevofluraneGABRG1/2/3, GABRP, GABRQQ8N1C3/P18507/Q99928, O00591, Q9UN88PAM

GABRA1: gamma-aminobutyric acid receptor subunit alpha-1; glycine receptor subunit alpha-1; glutamate receptor 1; potassium voltage-gate channel subfamily A member 1; calcium-transporting ATPase type 2C member 1; ATP synthase subunit delta, mitochondrial; NADH-ubiquinone oxidoreductase chain 1; GABA-A receptor (anion channel); PAM: positive allosteric modulator.